Inventor · disambiguated record
Marc Evanchik
Also filed as: EVANCHIK MARC · EVANCHIK MARC J · EVANCHIK MARC JUSTIN
20 granted patents·19 pending applications·108 citations·filing 2001–2025
94Inventor score
Files withMYOKARDIA INC173 V BIOSCIENCES INC9SAGIMET BIOSCIENCES INC4EDGEWISE THERAPEUTICS INC3ADELMAN DANIEL C2
Top patents by PatentIndex Score
39 records- 0194US9181200B2Pyrimidinedione compoundsMYOKARDIA INC·Filed 2014·Granted Nov 10, 2015·22 cites·19 claims
- 0293US9663516B2Bicyclic-pyrimidinedione compoundsMYOKARDIA INC·Filed 2015·Granted May 30, 2017·10 cites·31 claims
- 0393US9199945B2Cycloalkyl-substituted pyrimidinedione compoundsMYOKARDIA INC·Filed 2014·Granted Dec 1, 2015·12 cites·20 claims
- 0491US9809591B2Heterocyclic modulators of lipid synthesis3-V BIOSCIENCES INC·Filed 2015·Granted Nov 7, 2017·5 cites·10 claims
- 0591US8871790B2Heterocyclic modulators of lipid synthesisOSLOB JOHAN D·Filed 2012·Granted Oct 28, 2014·16 cites·21 claims
- 0691US8124773B21,8-naphthyridine compounds for the treatment of cancerADELMAN DANIEL C·Filed 2007·Granted Feb 28, 2012·10 cites·13 claims
- 0789US11622968B2Heterocyclic modulators of lipid synthesisSAGIMET BIOSCIENCES INC·Filed 2020·Granted Apr 11, 2023·2 cites·19 claims
- 0888US2024382486A1Pyrimidinedione compoundsMYOKARDIA INC·Filed 2024·Application pending·0 cites
- 0987US9624173B2Heterocyclic modulators of lipid synthesis3-V BIOSCIENCES INC·Filed 2015·Granted Apr 18, 2017·5 cites·19 claims
- 1087US9585883B2Pyrimidinedione compoundsMYOKARDIA INC·Filed 2015·Granted Mar 7, 2017·5 cites·18 claims
- 1185US10118913B2Heterocyclic modulators of lipid synthesis3 V BIOSCIENCES INC·Filed 2018·Granted Nov 6, 2018·4 cites·20 claims
- 1285US9428502B2Heterocyclic modulators of lipid synthesis3-V BIOSCIENCES INC·Filed 2014·Granted Aug 30, 2016·7 cites·22 claims
- 1384US2024423981A1Treatment of hcm with pyrimidinedione compoundsMYOKARDIA INC·Filed 2024·Application pending·0 cites
- 1483US2023165860A1Pyrimidinedione compoundsMYOKARDIA INC·Filed 2023·Application pending·0 cites
- 1582US10053450B2Heterocyclic modulators of lipid synthesis3 V BIOSCIENCES INC·Filed 2016·Granted Aug 21, 2018·3 cites·33 claims
- 1680USRE50050EPyrimidinedione compoundsMYOKARDIA INC·Filed 2022·Granted Jul 23, 2024·0 cites·23 claims
- 1780US10189822B2Heterocyclic modulators of lipid synthesis3 V BIOSCIENCES INC·Filed 2016·Granted Jan 29, 2019·4 cites·13 claims
- 1878US11034690B2Heterocyclic modulators of lipid synthesisSAGIMET BIOSCIENCES INC·Filed 2017·Granted Jun 15, 2021·2 cites·19 claims
- 1977US2025213565A1Treatment of hcm with pyrimidinedione compoundsMYOKARDIA INC·Filed 2025·Application pending·0 cites
- 2077US2022313695A1Treatment of hcm with pyrimidinedione compoundsMYOKARDIA INC·Filed 2022·Application pending·0 cites
- 2176US8765954B21,8-naphthyridine compounds for the treatment of cancerADELMAN DANIEL C·Filed 2012·Granted Jul 1, 2014·1 cites·8 claims
- 2276US2022226324A1Treatment of hcm with pyrimidinedione compoundsMYOKARDIA INC·Filed 2022·Application pending·0 cites
- 2374US2021346379A1Pyrimidinedione compoundsMYOKARDIA INC·Filed 2021·Application pending·0 cites
- 2472US12448369B2Quinolinone amide compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2024·Granted Oct 21, 2025·0 cites·56 claims
- 2572US2024400552A1Heterocyclic modulators of lipid synthesisSAGIMET BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2672US2020297726A1Pyrimidinedione compoundsMYOKARDIA INC·Filed 2020·Application pending·0 cites
- 2771US2020054636A1Treatment of hcm with pyrimidinedione compoundsMYOKARDIA INC·Filed 2019·Application pending·0 cites
- 2870US12509431B21,4-dihydroquinazolinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2024·Granted Dec 30, 2025·0 cites·30 claims
- 2970US2015150858A1Compounds and compositions for treatment of cancerSUNESIS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3065US2018311242A1Pyrimidinedione compoundsMYOKARDIA INC·Filed 2018·Application pending·0 cites
- 3164US2019269694A1Heterocyclic modulators of lipid synthesis3 V BIOSCIENCES INC·Filed 2018·Application pending·0 cites
- 3263US2014322355A1Heterocyclic modulators of lipid synthesis3 V BIOSCIENCES INC·Filed 2014·Application pending·0 cites
- 3362US2017281626A1Pyrimidinedione compoundsMYOKARDIA INC·Filed 2017·Application pending·0 cites
- 3461US9676774B2Compounds and compositions for treatment of cancerSUNESIS PHARMACEUTICALS INC·Filed 2016·Granted Jun 13, 2017·0 cites·6 claims
- 3561US2022340556A1Heterocyclic modulators of lipid synthesisSAGIMET BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 3660US2025361213A11,4-dihydroquinazolinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3751US2016031862A1Cycloalkyl-substituted pyrimidinedione compoundsMYOKARDIA INC·Filed 2015·Application pending·0 cites
- 3849US2003054430A1Stoichiometry measurements for the parameterization of absolute rate models for cytochrome P450 metabolismCAMITRO CORP·Filed 2001·Application pending·0 cites
- 3945US10226449B2Heterocyclic modulators of lipid synthesis and combinations thereof3 V BIOSCIENCES INC·Filed 2014·Granted Mar 12, 2019·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →